查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1459777

足底筋膜炎治療市場（類型：藥物治療、矯正器、衝擊波治療、手術等）- 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Plantar Fasciitis Treatment Market (Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 187 Pages | 商品交期: 2-10個工作天內

價格

足底筋膜炎治療市場 - 報告範圍

TMR 關於全球足底筋膜炎治療市場的報告研究了過去以及當前的成長趨勢和機會，以獲得2023 年至2031 年預測期內市場指標的寶貴見解。該報告提供了全球足底筋膜炎治療的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球足底筋膜炎治療市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解足底筋膜炎治療市場。

市場概況
2022年市場價​​值 7.783 億美元
2031 年市場價值 11 億美元
CAGR 4.3%

該報告深入探討了全球足底筋膜炎治療市場的競爭格局。全球足底筋膜炎治療市場的主要參與者已經確定，並且每位參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球足底筋膜炎治療市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：按類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按類型，2017-2031
    • 藥物治療
      • 口服
      • 注射用
    • 衝擊波療法
      • 體外震波療法 (ESWT)
      • 體內氣動衝擊波療法 (IPST)
    • 手術
    • 矯正器
    • 其他
  • 市場吸引力分析：按類型

第 7 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫院
    • 診所
    • 其他
  • 市場吸引力分析：按最終用戶

第 8 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 9 章：北美市場分析與預測

第 10 章：歐洲市場分析與預測

第 11 章：亞太市場分析與預測

第 12 章：拉丁美洲市場分析與預測

第 13 章：中東和非洲市場分析與預測

第 14 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Hanger, Inc.
    • Bayer Group (Dr. Scholl's)
    • A. Algeo Limited
    • Bauerfeind AG
    • Superfeet Worldwide, Inc.
    • Ottobock SE & Co. KGaA (Ottobock Holding)
    • Pfizer, Inc.
    • Sanofi
    • GlaxoSmithKline plc
Product Code: TMRGL47658

Plantar Fasciitis Treatment Market - Scope of Report

TMR's report on the global plantar fasciitis treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global plantar fasciitis treatment market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global plantar fasciitis treatment market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the plantar fasciitis treatment market.

Market Snapshot
Market Value in 2022US$ 778.3 Mn
Market Value in 2031US$ 1.1 Bn
CAGR4.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global plantar fasciitis treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global plantar fasciitis treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global plantar fasciitis treatment market.

The report delves into the competitive landscape of the global plantar fasciitis treatment market. Key players operating in the global plantar fasciitis treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global plantar fasciitis treatment market profiled in this report.

Key Questions Answered in Global plantar fasciitis treatment Market Report:

  • What is the sales/revenue generated by plantar fasciitis treatment across all regions during the forecast period?
  • What are the opportunities in the global plantar fasciitis treatment market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Plantar Fasciitis Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global plantar fasciitis treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global plantar fasciitis treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global plantar fasciitis treatment market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Plantar Fasciitis Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Plantar Fasciitis Treatment Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Medication Therapy
      • 6.3.1.1. Oral
      • 6.3.1.2. Parenteral
    • 6.3.2. Shockwave Therapy
      • 6.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 6.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 6.3.3. Surgery
    • 6.3.4. Orthotics
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Plantar Fasciitis Treatment Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2017-2031
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Plantar Fasciitis Treatment Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Market Value Forecast, by Type, 2017-2031
    • 9.3.1. Medication Therapy
      • 9.3.1.1. Oral
      • 9.3.1.2. Parenteral
    • 9.3.2. Shockwave Therapy
      • 9.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 9.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 9.3.3. Surgery
    • 9.3.4. Orthotics
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by End-user, 2017-2031
    • 9.4.1. Hospitals
    • 9.4.2. Clinics
    • 9.4.3. Others
  • 9.5. Market Value Forecast, by Country, 2017-2031
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Type
    • 9.6.2. By End-user
    • 9.6.3. By Country

10. Europe Plantar Fasciitis Treatment Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Type, 2017-2031
    • 10.3.1. Medication Therapy
      • 10.3.1.1. Oral
      • 10.3.1.2. Parenteral
    • 10.3.2. Shockwave Therapy
      • 10.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 10.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 10.3.3. Surgery
    • 10.3.4. Orthotics
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Clinics
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By End-user
    • 10.6.3. By Country/Sub-region

11. Asia Pacific Plantar Fasciitis Treatment Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Type, 2017-2031
    • 11.3.1. Medication Therapy
      • 11.3.1.1. Oral
      • 11.3.1.2. Parenteral
    • 11.3.2. Shockwave Therapy
      • 11.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 11.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 11.3.3. Surgery
    • 11.3.4. Orthotics
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Clinics
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. China
    • 11.5.2. Japan
    • 11.5.3. India
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By End-user
    • 11.6.3. By Country/Sub-region

12. Latin America Plantar Fasciitis Treatment Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Type, 2017-2031
    • 12.3.1. Medication Therapy
      • 12.3.1.1. Oral
      • 12.3.1.2. Parenteral
    • 12.3.2. Shockwave Therapy
      • 12.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 12.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 12.3.3. Surgery
    • 12.3.4. Orthotics
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Clinics
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By End-user
    • 12.6.3. By Country/Sub-region

13. Middle East & Africa Plantar Fasciitis Treatment Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Type, 2017-2031
    • 13.3.1. Medication Therapy
      • 13.3.1.1. Oral
      • 13.3.1.2. Parenteral
    • 13.3.2. Shockwave Therapy
      • 13.3.2.1. Extracorporeal Shock Wave Therapy (ESWT)
      • 13.3.2.2. Intracorporeal Pneumatic Shockwave Therapy (IPST)
    • 13.3.3. Surgery
    • 13.3.4. Orthotics
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Clinics
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. GCC Countries
    • 13.5.2. South Africa
    • 13.5.3. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By End-user
    • 13.6.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Hanger, Inc.
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Financial Overview
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Bayer Group (Dr. Scholl's)
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Financial Overview
      • 14.3.2.5. Strategic Overview
    • 14.3.3. A. Algeo Limited
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Financial Overview
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Bauerfeind AG
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Financial Overview
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Superfeet Worldwide, Inc.
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Financial Overview
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Ottobock SE & Co. KGaA (Ottobock Holding)
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Financial Overview
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Pfizer, Inc.
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Financial Overview
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Sanofi
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Financial Overview
      • 14.3.8.5. Strategic Overview
    • 14.3.9. GlaxoSmithKline plc
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Financial Overview
      • 14.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 05: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 08: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 11: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 14: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 17: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Middle East & Africa Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Plantar Fasciitis Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by Type, 2022
  • Figure 03: Global Plantar Fasciitis Treatment Market Value Share, by Type, 2022
  • Figure 04: Global Plantar Fasciitis Treatment Market Revenue (US$ Mn), by End-user, 2022
  • Figure 05: Global Plantar Fasciitis Treatment Market Value Share, by End-user, 2022
  • Figure 06: Global Plantar Fasciitis Treatment Market Value Share, by Region, 2022
  • Figure 07: Global Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 08: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 09: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 10: Global Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 11: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 12: Global Plantar Fasciitis Treatment Market Value Share Analysis, by Region, 2022-2031
  • Figure 13: Global Plantar Fasciitis Treatment Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 14: North America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 15: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 16: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Country, 2022-2031
  • Figure 17: North America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 18: North America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 19: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 20: North America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 21: Europe Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 22: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 23: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 24: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 25: Europe Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 26: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 27: Europe Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 28: Asia Pacific Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 29: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 30: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 31: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 32: Asia Pacific Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 34: Asia Pacific Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 35: Latin America Plantar Fasciitis Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 36: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 38: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 39: Latin America Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 40: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 41: Latin America Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 42: Middle East & Africa Plantar Fasciitis Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 43: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 45: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by Type, 2022-2031
  • Figure 46: Middle East & Africa Plantar Fasciitis Treatment Market Value Share Analysis, by End-user, 2022-2031
  • Figure 47: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by Type, 2023-2031
  • Figure 48: Middle East & Africa Plantar Fasciitis Treatment Market Attractiveness Analysis, by End-user, 2023-2031